Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates

Go back to Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
(NASDAQ: AUTL) Delayed: 2.24 --0 (-0%)
Previous Close $2.24    52 Week High
Open $2.24    52 Week Low
Day High $2.24    P/E N/A 
Day Low $2.24    EPS
Volume 202       

(NASDAQ: AUTL) Delayed: 2.24 --0 (-0%)
Previous Close $2.24    52 Week High
Open $2.24    52 Week Low
Day High $2.24    P/E N/A 
Day Low $2.24    EPS
Volume 202